Connection

Eric Rovner to Humans

This is a "connection" page, showing publications Eric Rovner has written about Humans.
Connection Strength

1.543
  1. Update on Urethral Bulking for Stress Urinary Incontinence in Women. Curr Urol Rep. 2022 Oct; 23(10):203-209.
    View in: PubMed
    Score: 0.032
  2. Is it the Surgeon? A Re-examination of Mid-urethral Sling Complications. Urology. 2021 11; 157:269-273.
    View in: PubMed
    Score: 0.030
  3. Urinary retention after AdVance? Sling: A multi-institutional retrospective study. Neurourol Urodyn. 2021 01; 40(1):515-521.
    View in: PubMed
    Score: 0.028
  4. Do urodynamics predict urinary retention after sling placement in the complex patient: the value of reproducing symptoms on urodynamics. Int Urogynecol J. 2021 Jan; 32(1):81-86.
    View in: PubMed
    Score: 0.028
  5. Persistent Dysuria in a Young Male. Urology. 2021 02; 148:e29-e30.
    View in: PubMed
    Score: 0.028
  6. Shortness of Breath Secondary to a Massive Bladder Diverticulum: A Unique Transvesical Repair. Urology. 2020 08; 142:e1-e3.
    View in: PubMed
    Score: 0.027
  7. Is polypropylene mesh material fundamentally safe for use as a reconstructive material in vaginal surgery: ICI-RS 2019? Neurourol Urodyn. 2020 07; 39 Suppl 3:S132-S139.
    View in: PubMed
    Score: 0.027
  8. Evaluating the safety and potential activity of URO-902 (hMaxi-K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non-neurogenic) overactive bladder syndrome and detrusor overactivity from two double-blind, imbalanced, placebo-controlled randomized phase 1 trials. Neurourol Urodyn. 2020 02; 39(2):744-753.
    View in: PubMed
    Score: 0.027
  9. One-year results with selective bladder denervation in women with refractory overactive bladder. Neurourol Urodyn. 2019 11; 38(8):2178-2184.
    View in: PubMed
    Score: 0.026
  10. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019 05; 201(5):967-972.
    View in: PubMed
    Score: 0.025
  11. The Use of Tissue Flaps in the Management of Urinary Tract Fistulas. Curr Urol Rep. 2019 Apr 30; 20(6):32.
    View in: PubMed
    Score: 0.025
  12. A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology. Contemp Clin Trials. 2018 07; 70:83-87.
    View in: PubMed
    Score: 0.024
  13. Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon. Neurourol Urodyn. 2018 01; 37(1):440-448.
    View in: PubMed
    Score: 0.023
  14. Outcomes of treatment of stress urinary incontinence associated with female urethral diverticula: A selective approach. Neurourol Urodyn. 2018 01; 37(1):478-484.
    View in: PubMed
    Score: 0.022
  15. Transvaginal approach to distal ureterectomy in an obstructed remnant. Int Urogynecol J. 2017 Sep; 28(9):1431-1433.
    View in: PubMed
    Score: 0.022
  16. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study. Low Urin Tract Symptoms. 2018 Sep; 10(3):221-230.
    View in: PubMed
    Score: 0.022
  17. Analysis of Complications of Pelvic Mesh Excision Surgery Using the Clavien-Dindo Classification System. J Urol. 2017 09; 198(3):638-643.
    View in: PubMed
    Score: 0.022
  18. Dimethyl sulfoxide (DMSO) as intravesical therapy for interstitial cystitis/bladder pain syndrome: A review. Neurourol Urodyn. 2017 Sep; 36(7):1677-1684.
    View in: PubMed
    Score: 0.022
  19. Stress urinary incontinence surgery trends in academic female pelvic medicine and reconstructive surgery urology practice in the setting of the food and drug administration public health notifications. Neurourol Urodyn. 2017 04; 36(4):1155-1160.
    View in: PubMed
    Score: 0.021
  20. Lower urinary tract symptoms in women: epidemiology, diagnosis, and management. Curr Opin Urol. 2016 07; 26(4):328-33.
    View in: PubMed
    Score: 0.021
  21. A case of uncomplicated urinary myiasis in a healthy female. BMJ Case Rep. 2016 Jun 23; 2016.
    View in: PubMed
    Score: 0.021
  22. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol. 2016 Sep; 196(3):801-8.
    View in: PubMed
    Score: 0.021
  23. Female Urethral Diverticula in the Contemporary Era: Is the Classic Triad of the "3Ds" Still Relevant? Urology. 2016 Aug; 94:53-6.
    View in: PubMed
    Score: 0.020
  24. Outcomes of Autologous Fascia Pubovaginal Sling for Patients with Transvaginal Mesh Related Complications Requiring Mesh Removal. J Urol. 2016 Aug; 196(2):484-9.
    View in: PubMed
    Score: 0.020
  25. Pelvic Organ Prolapse Surgery in Academic Female Pelvic Medicine and Reconstructive Surgery Urology Practice in the Setting of the Food and Drug Administration Public Health Notifications. Urology. 2016 05; 91:46-51.
    View in: PubMed
    Score: 0.020
  26. New treatments for incontinence. Adv Chronic Kidney Dis. 2015 Jul; 22(4):279-88.
    View in: PubMed
    Score: 0.019
  27. Removal of Polypropylene Sling Mesh From the Urethra: An Anatomic Technique. Urology. 2015 Jul; 86(1):196-9.
    View in: PubMed
    Score: 0.019
  28. Progress in stress incontinence surgery--are we destined to fail? J Urol. 2015 Mar; 193(3):758-9.
    View in: PubMed
    Score: 0.019
  29. Simple vs complex urethral diverticulum: presentation and outcomes. Urology. 2014 Dec; 84(6):1516-9.
    View in: PubMed
    Score: 0.019
  30. Patient perception of transvaginal mesh and the media. Urology. 2014 Sep; 84(3):575-82.
    View in: PubMed
    Score: 0.018
  31. Management of failed stress urinary incontinence surgery. Curr Urol Rep. 2014 Aug; 15(8):429.
    View in: PubMed
    Score: 0.018
  32. Chapter 6: Practical aspects of administration of onabotulinumtoxinA. Neurourol Urodyn. 2014 Jul; 33 Suppl 3:S32-7.
    View in: PubMed
    Score: 0.018
  33. Good urodynamic practice: keys to performing a quality UDS study. Urol Clin North Am. 2014 Aug; 41(3):363-73, vii.
    View in: PubMed
    Score: 0.018
  34. Implications of the FDA statement on transvaginal placement of mesh: the aftermath. Curr Urol Rep. 2014 Feb; 15(2):380.
    View in: PubMed
    Score: 0.018
  35. A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence. J Urol. 2013 Dec; 190(6):2243-50.
    View in: PubMed
    Score: 0.017
  36. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2013 Nov; 32(8):1109-15.
    View in: PubMed
    Score: 0.016
  37. Sling location in women with recurrent stress urinary incontinence following midurethral sling. Urology. 2012 Jan; 79(1):76-9.
    View in: PubMed
    Score: 0.015
  38. Managing complications of slings. Curr Opin Urol. 2011 Jul; 21(4):291-6.
    View in: PubMed
    Score: 0.015
  39. Transvaginal bladder neck closure with posterior urethral flap for devastated urethra. Urology. 2011 Jul; 78(1):208-12.
    View in: PubMed
    Score: 0.015
  40. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn. 2011 Apr; 30(4):556-62.
    View in: PubMed
    Score: 0.014
  41. Effect of A 7-F transurethral catheter on abdominal leak point pressure measurement in men with post-prostatectomy incontinence. Urology. 2011 May; 77(5):1188-93.
    View in: PubMed
    Score: 0.014
  42. Predicting for postoperative incontinence following sling incision. Int Urogynecol J. 2011 Jun; 22(6):665-9.
    View in: PubMed
    Score: 0.014
  43. An update on surgery for pelvic organ prolapse. Curr Opin Urol. 2010 Nov; 20(6):490-4.
    View in: PubMed
    Score: 0.014
  44. Urodynamics in the evaluation of overactive bladder. Curr Urol Rep. 2010 Sep; 11(5):343-7.
    View in: PubMed
    Score: 0.014
  45. Frequently asked questions in the evaluation and management of overactive bladder. J Fam Pract. 2009 Oct; 58(10 Suppl):S1-11; quiz S12.
    View in: PubMed
    Score: 0.013
  46. Stress incontinence surgery: which operation when? Curr Opin Urol. 2009 Jul; 19(4):362-7.
    View in: PubMed
    Score: 0.013
  47. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. J Urol. 2008 Sep; 180(3):1034-41.
    View in: PubMed
    Score: 0.012
  48. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93.
    View in: PubMed
    Score: 0.012
  49. Adherence to the 1997 American Urological Association guidelines for the surgical treatment of stress urinary incontinence. Urology. 2008 Feb; 71(2):239-42.
    View in: PubMed
    Score: 0.012
  50. Sexual health in adult men with spina bifida. ScientificWorldJournal. 2007 Sep 01; 7:1466-9.
    View in: PubMed
    Score: 0.011
  51. Complications of anterior compartment vaginal surgery. Curr Urol Rep. 2007 Sep; 8(5):405-12.
    View in: PubMed
    Score: 0.011
  52. Urethral diverticula: a review and an update. Neurourol Urodyn. 2007; 26(7):972-7.
    View in: PubMed
    Score: 0.011
  53. Vaginal erosion after hybrid midurethral sling placement. Urology. 2006 Dec; 68(6):1343.e13-4.
    View in: PubMed
    Score: 0.011
  54. Trospium chloride: the European experience. Expert Opin Pharmacother. 2006 Jul; 7(10):1373-80.
    View in: PubMed
    Score: 0.010
  55. Female urethral strictures: successful management with long-term clean intermittent catheterization after urethral dilatation. BJU Int. 2006 Jul; 98(1):96-9.
    View in: PubMed
    Score: 0.010
  56. Long-term chronic complications from Stamey endoscopic bladder neck suspension: a case series. Int Urogynecol J Pelvic Floor Dysfunct. 2006 May; 17(3):290-4.
    View in: PubMed
    Score: 0.010
  57. Tolterodine for the treatment of overactive bladder: a review. Expert Opin Pharmacother. 2005 Apr; 6(4):653-66.
    View in: PubMed
    Score: 0.010
  58. Bone anchors for stress urinary incontinence in 2004: con. Urology. 2004 Nov; 64(5):851-4.
    View in: PubMed
    Score: 0.009
  59. Complications of prostate cancer treatment: spectrum of imaging findings. Radiographics. 2004 Oct; 24 Suppl 1:S181-94.
    View in: PubMed
    Score: 0.009
  60. Pharmacologic management of urinary incontinence in the female. Minerva Ginecol. 2004 Aug; 56(4):327-47.
    View in: PubMed
    Score: 0.009
  61. Urodynamically defined stress urinary incontinence and bladder outlet obstruction coexist in women. J Urol. 2004 Feb; 171(2 Pt 1):757-60; discussion 760-1.
    View in: PubMed
    Score: 0.009
  62. Trospium chloride in the management of overactive bladder. Drugs. 2004; 64(21):2433-46.
    View in: PubMed
    Score: 0.009
  63. Update on overactive bladder: pharmacologic approaches on the horizon. Curr Urol Rep. 2003 Oct; 4(5):385-90.
    View in: PubMed
    Score: 0.009
  64. Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol. 2003 Jul; 170(1):82-6; discussion 86.
    View in: PubMed
    Score: 0.008
  65. Evaluation of lower urinary tract symptoms in females. Curr Opin Urol. 2003 Jul; 13(4):273-8.
    View in: PubMed
    Score: 0.008
  66. Vaginal erosion after pubovaginal sling procedures using dermal allografts. J Urol. 2003 Jan; 169(1):286-7.
    View in: PubMed
    Score: 0.008
  67. Definition and epidemiology of overactive bladder. Urology. 2002 Nov; 60(5 Suppl 1):7-12; discussion 12.
    View in: PubMed
    Score: 0.008
  68. Pharmacologic management of urinary incontinence in women. Urol Clin North Am. 2002 Aug; 29(3):537-50, viii.
    View in: PubMed
    Score: 0.008
  69. Does urinary urgency drive urinary frequency in overactive bladder? Low Urin Tract Symptoms. 2022 Jul; 14(4):242-247.
    View in: PubMed
    Score: 0.008
  70. Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. Eur Urol. 2002 Jan; 41(1):6-14.
    View in: PubMed
    Score: 0.008
  71. Evaluation and treatment of the overactive bladder. Rev Hosp Clin Fac Med Sao Paulo. 2002 Jan-Feb; 57(1):39-48.
    View in: PubMed
    Score: 0.008
  72. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Diagnosis and Evaluation. J Urol. 2021 Nov; 206(5):1097-1105.
    View in: PubMed
    Score: 0.007
  73. The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up. J Urol. 2021 Nov; 206(5):1106-1113.
    View in: PubMed
    Score: 0.007
  74. Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study. Low Urin Tract Symptoms. 2021 Oct; 13(4):425-434.
    View in: PubMed
    Score: 0.007
  75. Severe urinary tract damage secondary to primary bladder neck obstruction in women. PLoS One. 2021; 16(3):e0248938.
    View in: PubMed
    Score: 0.007
  76. Urinary fistula between the bladder and lower extremity following Burch urethropexy. J Urol. 2001 Feb; 165(2):525-6.
    View in: PubMed
    Score: 0.007
  77. Significance of hematuria in patients with interstitial cystitis: review of radiographic and endoscopic findings. Urology. 2001 Feb; 57(2):262-5.
    View in: PubMed
    Score: 0.007
  78. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology. 2000 Dec 20; 56(6):940-5.
    View in: PubMed
    Score: 0.007
  79. Pelvic organ prolapse: a review. Ostomy Wound Manage. 2000 Dec; 46(12):24-37.
    View in: PubMed
    Score: 0.007
  80. Treatment of urinary incontinence. Curr Urol Rep. 2000 Oct; 1(3):235-44.
    View in: PubMed
    Score: 0.007
  81. Angiomyolipoma of the renal sinus: diagnosis by percutaneous biopsy. Urology. 2000 Feb; 55(2):286.
    View in: PubMed
    Score: 0.007
  82. Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents. J Vis Exp. 2020 01 31; (155).
    View in: PubMed
    Score: 0.007
  83. Ventral hernia of the urinary bladder with mixed urinary incontinence: treatment with herniorrhaphy and allograft fascial sling. Urology. 2000 Jan; 55(1):145.
    View in: PubMed
    Score: 0.007
  84. Organ-sparing surgery for bilateral leydig cell tumor of the testis. Urology. 1999 Oct; 54(4):744.
    View in: PubMed
    Score: 0.007
  85. Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE). Adv Ther. 2019 08; 36(8):1906-1921.
    View in: PubMed
    Score: 0.006
  86. Extraperitoneal laparoscopic urethropexy with Marlex mesh. Urology. 1999 May; 53(5):985-9.
    View in: PubMed
    Score: 0.006
  87. Images in clinical urology. Magnetic resonance imaging of a "saddle bag" urethral diverticulum. Urology. 1999 Apr; 53(4):818-9.
    View in: PubMed
    Score: 0.006
  88. The overactive bladder: an overview for primary care health providers. Int J Fertil Womens Med. 1999 Mar-Apr; 44(2):56-66.
    View in: PubMed
    Score: 0.006
  89. Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder. J Urol. 2019 03; 201(3):573-580.
    View in: PubMed
    Score: 0.006
  90. Surgery for urinary incontinence in women: Report from the 6th international consultation on incontinence. Neurourol Urodyn. 2019 02; 38(2):825-837.
    View in: PubMed
    Score: 0.006
  91. Study design and outcomes measures: The influence of composite endpoints and other design variables on outcomes in a study of a novel device for stress urinary incontinence. Neurourol Urodyn. 2018 11; 37(8):2919-2927.
    View in: PubMed
    Score: 0.006
  92. Why anti-incontinence surgery succeeds or fails. Clin Obstet Gynecol. 1998 Sep; 41(3):719-34.
    View in: PubMed
    Score: 0.006
  93. Re: Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. J Urol. 1998 May; 159(5):1646-7.
    View in: PubMed
    Score: 0.006
  94. Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon. Female Pelvic Med Reconstr Surg. 2018 May/Jun; 24(3):222-231.
    View in: PubMed
    Score: 0.006
  95. Primary slings for everyone with genuine stress incontinence? The argument against. Int Urogynecol J 1997,8:321-322. Int Urogynecol J Pelvic Floor Dysfunct. 1998; 9(6):419.
    View in: PubMed
    Score: 0.006
  96. Individualizing Urinary Incontinence Treatment: Research Needs Identified at NIDDK Workshop. J Urol. 2018 06; 199(6):1405-1407.
    View in: PubMed
    Score: 0.006
  97. A method for intraoperative adjustment of sling tension: prevention of outlet obstruction during vaginal wall sling. Urology. 1997 Aug; 50(2):273-6.
    View in: PubMed
    Score: 0.006
  98. Nongenomic modulation of the large conductance voltage- and Ca2+-activated K+ channels by estrogen: A novel regulatory mechanism in human detrusor smooth muscle. Physiol Rep. 2017 Jul; 5(14).
    View in: PubMed
    Score: 0.006
  99. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol. 1997 Jul; 158(1):138-41; discussion 141-2.
    View in: PubMed
    Score: 0.006
  100. Regulation of transient receptor potential melastatin 4 channel by sarcoplasmic reticulum inositol trisphosphate receptors: Role in human detrusor smooth muscle function. Channels (Austin). 2017 Sep 03; 11(5):459-466.
    View in: PubMed
    Score: 0.006
  101. The UCLA surgical approach to sphincteric incontinence in women. World J Urol. 1997; 15(5):280-94.
    View in: PubMed
    Score: 0.005
  102. A three dimensional nerve map of human bladder trigone. Neurourol Urodyn. 2017 04; 36(4):1015-1019.
    View in: PubMed
    Score: 0.005
  103. BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function. Am J Physiol Renal Physiol. 2016 05 15; 310(10):F994-9.
    View in: PubMed
    Score: 0.005
  104. Novel regulatory mechanism in human urinary bladder: central role of transient receptor potential melastatin 4 channels in detrusor smooth muscle function. Am J Physiol Cell Physiol. 2016 Apr 01; 310(7):C600-11.
    View in: PubMed
    Score: 0.005
  105. Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2016 06; 35(5):595-600.
    View in: PubMed
    Score: 0.005
  106. Functional link between muscarinic receptors and large-conductance Ca2+ -activated K+ channels in freshly isolated human detrusor smooth muscle cells. Pflugers Arch. 2015 Apr; 467(4):665-75.
    View in: PubMed
    Score: 0.004
  107. Position statement on mesh midurethral slings for stress urinary incontinence. Female Pelvic Med Reconstr Surg. 2014 May-Jun; 20(3):123-5.
    View in: PubMed
    Score: 0.004
  108. BRL37344, a ?3-adrenergic receptor agonist, decreases nerve-evoked contractions in human detrusor smooth muscle isolated strips: role of BK channels. Urology. 2013 Sep; 82(3):744.e1-7.
    View in: PubMed
    Score: 0.004
  109. Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels. PLoS One. 2013; 8(7):e68052.
    View in: PubMed
    Score: 0.004
  110. Single-channel biophysical and pharmacological characterizations of native human large-conductance calcium-activated potassium channels in freshly isolated detrusor smooth muscle cells. Pflugers Arch. 2013 Jul; 465(7):965-75.
    View in: PubMed
    Score: 0.004
  111. SK channel-selective opening by SKA-31 induces hyperpolarization and decreases contractility in human urinary bladder smooth muscle. Am J Physiol Regul Integr Comp Physiol. 2013 Jan 15; 304(2):R155-63.
    View in: PubMed
    Score: 0.004
  112. Urodynamic studies in adults: AUA/SUFU guideline. J Urol. 2012 Dec; 188(6 Suppl):2464-72.
    View in: PubMed
    Score: 0.004
  113. Selective inhibition of phosphodiesterase 1 relaxes urinary bladder smooth muscle: role for ryanodine receptor-mediated BK channel activation. Am J Physiol Cell Physiol. 2012 Nov 15; 303(10):C1079-89.
    View in: PubMed
    Score: 0.004
  114. Constitutively active phosphodiesterase activity regulates urinary bladder smooth muscle function: critical role of KCa1.1 channel. Am J Physiol Renal Physiol. 2012 Nov 01; 303(9):F1300-6.
    View in: PubMed
    Score: 0.004
  115. Investigation of a Ca2+ channel a2d ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial. J Urol. 2012 Sep; 188(3):817-23.
    View in: PubMed
    Score: 0.004
  116. SK but not IK channels regulate human detrusor smooth muscle spontaneous and nerve-evoked contractions. Am J Physiol Renal Physiol. 2012 Aug 15; 303(4):F559-68.
    View in: PubMed
    Score: 0.004
  117. The management of overactive bladder syndrome. BMJ. 2012 Apr 17; 344:e2365.
    View in: PubMed
    Score: 0.004
  118. Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1599-608.
    View in: PubMed
    Score: 0.004
  119. Suppression of human detrusor smooth muscle excitability and contractility via pharmacological activation of large conductance Ca2+-activated K+ channels. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1632-41.
    View in: PubMed
    Score: 0.004
  120. Large-conductance voltage- and Ca2+-activated K+ channels regulate human detrusor smooth muscle function. Am J Physiol Cell Physiol. 2011 Oct; 301(4):C903-12.
    View in: PubMed
    Score: 0.004
  121. Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials. Drugs Aging. 2011 Feb 01; 28(2):151-60.
    View in: PubMed
    Score: 0.004
  122. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged = 75 years) with overactive bladder syndrome. BJU Int. 2011 Feb; 107(4):612-20.
    View in: PubMed
    Score: 0.003
  123. Which injectable to use in the treatment of intrinsic sphincter deficiency? Curr Opin Urol. 2010 Jul; 20(4):296-301.
    View in: PubMed
    Score: 0.003
  124. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol. 2010 May; 183(5):1906-14.
    View in: PubMed
    Score: 0.003
  125. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2010 Jan; 183(1):234-40.
    View in: PubMed
    Score: 0.003
  126. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010 May; 105(9):1276-82.
    View in: PubMed
    Score: 0.003
  127. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int. 2010 May; 105(9):1268-75.
    View in: PubMed
    Score: 0.003
  128. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of Zuidex via the Implacer versus proximal urethral injection of Contigen cystoscopically. Urology. 2009 Oct; 74(4):771-5.
    View in: PubMed
    Score: 0.003
  129. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009 Sep; 182(3):1055-61.
    View in: PubMed
    Score: 0.003
  130. Urology in pre-civil war Charleston. J Urol. 2008 Aug; 180(2):477-80.
    View in: PubMed
    Score: 0.003
  131. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008 May; 179(5):1850-6.
    View in: PubMed
    Score: 0.003
  132. Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May; 71(5):839-43.
    View in: PubMed
    Score: 0.003
  133. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007 Feb; 177(2):556-60.
    View in: PubMed
    Score: 0.003
  134. MRI of endocervicosis: an unusual cause of clustered periurethral cystic masses involving the bladder. AJR Am J Roentgenol. 2007 Feb; 188(2):W147-9.
    View in: PubMed
    Score: 0.003
  135. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006 Nov 15; 296(19):2319-28.
    View in: PubMed
    Score: 0.003
  136. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology. 2006 Aug; 68(2):328-32.
    View in: PubMed
    Score: 0.003
  137. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. BJU Int. 2006 May; 97(5):1003-6.
    View in: PubMed
    Score: 0.003
  138. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006 Apr; 67(4):731-6; discussion 736.
    View in: PubMed
    Score: 0.003
  139. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health. 2005 Nov-Dec; 8 Suppl 1:S25-34.
    View in: PubMed
    Score: 0.002
  140. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005 Jan; 173(1):93-7.
    View in: PubMed
    Score: 0.002
  141. A new questionnaire for urinary incontinence diagnosis in women: development and testing. Am J Obstet Gynecol. 2005 Jan; 192(1):66-73.
    View in: PubMed
    Score: 0.002
  142. Is urine methylhistamine a useful marker for interstitial cystitis? J Urol. 2004 Dec; 172(6 Pt 1):2256-60.
    View in: PubMed
    Score: 0.002
  143. Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis. Urology. 2003 May; 61(5):897-901.
    View in: PubMed
    Score: 0.002
  144. Urologic complications of nonurologic medications. Urol Clin North Am. 2003 Feb; 30(1):123-31.
    View in: PubMed
    Score: 0.002
  145. Endoluminal magnetic resonance imaging in the evaluation of urethral diverticula in women. Urology. 2001 Apr; 57(4):660-5.
    View in: PubMed
    Score: 0.002
  146. Renal vein thrombosis after martial arts trauma. J Trauma. 2001 Jan; 50(1):144-5.
    View in: PubMed
    Score: 0.002
  147. Simultaneous upper and lower urinary tract obstruction associated with severe genital prolapse: diagnosis and evaluation with magnetic resonance imaging. Int Urogynecol J Pelvic Floor Dysfunct. 2001; 12(2):144-6.
    View in: PubMed
    Score: 0.002
  148. Injected periurethral collagen for postprostatectomy urinary incontinence: MR and CT appearance. Abdom Imaging. 2000 Nov-Dec; 25(6):658-62.
    View in: PubMed
    Score: 0.002
  149. Colonic polyp in a urinary diversion causing hematuria: diagnosis on ultrasonography. J Ultrasound Med. 2000 Nov; 19(11):797-9.
    View in: PubMed
    Score: 0.002
  150. Continence mechanism based on a modified ileocecal valve. Tech Urol. 2000 Sep; 6(3):167-71.
    View in: PubMed
    Score: 0.002
  151. Erectile function and quality of life after interstitial radiation therapy for prostate cancer. Int J Impot Res. 2000 Sep; 12 Suppl 3:S18-24.
    View in: PubMed
    Score: 0.002
  152. Artificial urinary sphincter for post-prostatectomy incontinence: impact of prior collagen injection on cost and clinical outcome. J Urol. 2000 Jan; 163(1):87-90.
    View in: PubMed
    Score: 0.002
  153. 4-Defect repair of grade 4 cystocele. J Urol. 1999 Feb; 161(2):587-94.
    View in: PubMed
    Score: 0.002
  154. Posthysterectomy vaginal cuff fistula: diagnosis and management of an unusual cause of "incontinence". Urology. 1998 Jul; 52(1):61-4; discussion 64-5.
    View in: PubMed
    Score: 0.001
  155. Vaginal evisceration. Urology. 1998 Jan; 51(1):128-9.
    View in: PubMed
    Score: 0.001
  156. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. J Urol. 1996 Jan; 155(1):228-31.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.